市場調查報告書
商品編碼
1535830
大麻二酚 (CBD) 寵物市場 - 按寵物類型、產品類型、應用、配銷通路- 全球預測Cannabidiol (CBD) Pet Market - By Pet Type, Product Type, Application, Distribution Channel - Global Forecast 2024-2032 |
大麻二酚寵物市場規模從2024 年到2032 年的複合年成長率將達到18.2%,這主要是由於人們越來越關注產品供應的擴展,包括針對不同寵物需求量身定做的油、零食、膠囊和局部應用。例如,2022 年 5 月,波蘭大麻公司 Kombinat Konopny 披露了利用大麻二酚 (CBD) 油為貓和狗生產寵物零食和相關產品的計劃。最近,許多 CBD 產品都是針對特定條件而設計的,例如緩解焦慮、疼痛管理和關節支持。電子商務平台上 CBD 寵物產品的供應增加,使更廣泛的受眾更容易獲得這些產品,也將推動市場成長。
CBD寵物產業分為寵物類型、產品類型、應用、配銷通路、區域。
以寵物類型來看,由於潛在的健康益處,特別是在緩解疼痛、焦慮和整體健康方面,貓的產業價值預計將在 2024 年至 2032 年間出現利潤豐厚的成長。除了刺激生病或正在接受化療等治療的貓的食慾外,CBD還支持整體健康,並可以改善生活品質,尤其是老年貓。油、零食和外用等各種產品形式的開發也將促進該細分市場的成長。
在應用方面,疼痛管理領域的大麻二酚寵物市場佔有率將在 2032 年大幅擴張。隨著寵物主人擴大尋求傳統藥物的天然和整體替代品,CBD 已發展成為更安全、副作用更少的選擇。
從地區來看,由於城市生活的開始和小型寵物的日益普及,亞太地區 CBD 寵物產業規模可能會在 2024 年至 2032 年間出現顯著的複合年成長率。該地區越來越多的獸醫認知到並支持在寵物中使用 CBD 產品,進一步增強了消費者的信心。寵物主人越來越意識到 CBD 對寵物的健康益處,例如緩解疼痛、減少焦慮和整體健康,這將影響產品需求。
Cannabidiol Pet Market size will record 18.2% CAGR from 2024-2032, led by the growing focus on the expansion of product offerings, including oils, treats, capsules, and topical applications tailored to different pet needs. For example, in May 2022, Polish hemp firm Kombinat Konopny disclosed plans to produce pet treats and related products for cats and dogs by using cannabidiol (CBD) oil. Of late, numerous CBD products are designed for specific conditions, such as anxiety relief, pain management, and joint support. Increased availability of CBD pet products on e-commerce platforms for making them more accessible to a wider audience will also anchor the market growth.
The CBD pet industry is classified into pet type, product type, application, distribution channel, and region.
By pet type, the industry value from the cats segment is anticipated to witness lucrative growth between 2024 and 2032, owing to the potential health benefits, particularly for pain relief, anxiety, and overall wellness. In addition to stimulating appetite in cats who are ill or undergoing treatments like chemotherapy, CBD supports general health and can improve the quality of life, especially in aging cats. The development of various product forms, such as oils, treats, and topicals will also boost the segment growth.
In terms of application, the cannabidiol pet market share from the pain management segment will depict significant expansion through 2032. CBD offers anti-inflammatory properties that help reduce inflammation-related pain, making it beneficial for conditions like arthritis and inflammatory diseases. With pet owners increasingly seeking natural and holistic alternatives to traditional pharmaceuticals, CBD has evolved as a safer option with fewer side effects.
Regionally, the Asia Pacific CBD pet industry size may accrue a noteworthy CAGR between 2024 and 2032, due to the onset of urban living and the growing popularity of smaller pets. More veterinarians across the region are recognizing and endorsing the use of CBD products for pets, further increasing consumer confidence. Growing awareness among pet owners about the health benefits of CBD for pets, such as pain relief, anxiety reduction, and overall wellness will influence the product demand.